I encourage you to read the intermediate results of the study carried out by researchers at the University Sapienza in Rome concerning the effect of specific probiotic strains on HIV-positive patients under antiretroviral therapy. (1)

As you know, this subject is of special interest to me and I had commented the first article of Jannie Wright on the benefits of this probiotic mixture Visbiome (Vivomixx in Europe) on the reduction of an enzyme involved in neurodegeneration which ultimately affects numerous HIV-positive patients. (2)

Today, new results show how this specific combination of probiotic strains preserves the integrity of the intestinal barrier which is usually very degraded in these patients. By reducing the systemic inflammation linked to the collapse of the intestinal barrier, patients may benefit from enhanced immunity and a stronger resistance to HIV and anti-retroviral related comorbidities (diabetes, osteoporosis, heart disease, neurodegenerative diseases, etc.)

I am pleased with these new results which are very encouraging for the patient community and look forward to the conclusive results of the study expected early 2018 that I will be pleased to share on my blog.

Pr De Simone, about

1. http://www.businesswire.com/news/home/20170502006014/en
2. STUDY: Probiotic Could Help Prevent Disorders in People With HIV, by Jeannie Wraight, www.hivplusmag.com

Share this article!

Categories: DSF, HIV-AIDS, Probiotics